408 results on '"Slagboom, Ton"'
Search Results
2. EXpansion of stents after intravascular lithoTripsy versus conventional predilatation in CALCified coronary arteries
3. Impact of preprocedural left ventricular systolic function on the safety and durability of percutaneous coronary intervention
4. Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis
5. Influence of Bleeding Risk on Outcomes of Radial and Femoral Access for Percutaneous Coronary Intervention: An Analysis From the GLOBAL LEADERS Trial
6. Abstract 154: Limitation of Troponin T In Identifying the Cause of Out-of-hospital Cardiac Arrest
7. Efficacy and Safety of Stents in ST-Segment Elevation Myocardial Infarction
8. Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting
9. 2-Year Clinical Outcomes of an Abluminal Groove–Filled Biodegradable-Polymer Sirolimus-Eluting Stent Compared With a Durable-Polymer Everolimus-Eluting Stent
10. Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction: The REVELATION Randomized Trial
11. Comparison of a Novel Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent: 5-Year Outcomes of the Randomized BIOFLOW-II Trial
12. The SABRE Trial (Sirolimus Angioplasty Balloon for Coronary In-Stent Restenosis): Angiographic Results and 1-Year Clinical Outcomes
13. Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Final 5-Year Report From the COMPARE II Trial (Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent)
14. Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial
15. Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis
16. Dedicated Bifurcation Stent for the Treatment of Bifurcation Lesions Involving Large Side Branches: Outcomes From the Tryton Confirmatory Study
17. Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial
18. A Randomized Trial of a Dedicated Bifurcation Stent Versus Provisional Stenting in the Treatment of Coronary Bifurcation Lesions
19. Prospective, multi-center evaluation of a silicon carbide coated cobalt chromium bare metal stent for percutaneous coronary interventions: Two-year results of the ENERGY Registry
20. Y02 Determining Myocardial Infarction Using High Sensitive Troponin T in Out-of-Hospital Cardiac Arrest
21. PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens:Insights from the GLOBAL LEADERS and GLASSY
22. Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS Trial
23. 5-Year Clinical Outcomes of Paclitaxel-Coated Balloon Angioplasty vs DES in Acute MI: The REVELATION Trial
24. 5-Year Follow-Up After Primary Percutaneous Coronary Intervention With a Paclitaxel-Eluting Stent Versus a Bare-Metal Stent in Acute ST-Segment Elevation Myocardial Infarction: A Follow-Up Study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction With ST-Segment Elevation) Trial
25. Patency of Paclitaxel-Eluting Versus Bare Metal Stents Long Term After Implantation in Acute ST-Segment Elevation Myocardial Infarction
26. Recurrent Myocardial Infarction After Primary Percutaneous Coronary Intervention in Multivessel Coronary Disease Is Primarily Related to Stent Failure: Post-Hoc Analysis of the PASSION Trial
27. Implementation of a Prehospital Triage System for Patients With Chest Pain and Logistics for Primary Percutaneous Coronary Intervention in the Region of Amsterdam, The Netherlands
28. TCT-489 Three-Year Outcomes of Patients Treated With the Firehawk Stent Versus XIENCE Stent on the Basis of Diabetes Status: Subgroup Analysis of the TARGET All Comers Trial
29. Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial
30. A prospective, postmarket study with the Mguard Prime Embolic Protection Stent in ST-segment elevation myocardial infarction: The International MGuard Prime Observational Study (IMOS Prime)
31. One‐year mortality in NSTEMI patients is unaffected by timing of PCI within the first week of admission: Results of a real‐world cohort analysis
32. Impact of Coronary Calcification on Clinical Outcomes After Implantation of Newer‐Generation Drug‐Eluting Stents
33. Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY
34. Dedicated plug based closure for large bore access –The MARVEL prospective registry
35. Pronounced late acquired focal coronary artery dilatation after paclitaxel-coated balloon angioplasty: observations from the randomized REVascularization With PaclitaxEL-Coated Balloon Angioplasty Versus Drug-Eluting Stenting in Acute Myocardial InfarcTION (REVELATION) trial
36. Biodegradable polymer sirolimus-eluting stents vs durable polymer everolimus-eluting stents in patients undergoing percutaneous coronary intervention: A meta-analysis of individual patient data from 5 randomized trials
37. An immediate or early invasive strategy in non-ST-elevation acute coronary syndrome: The OPTIMA-2 randomized controlled trial
38. Additional file 1 of Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial
39. Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial
40. Comparison of Investigator-Reported and Clinical Event Committee–Adjudicated Outcome Events in GLASSY
41. Regional variation in patients and outcomes in the GLOBAL LEADERS trial
42. Dedicated plug based closure for large bore access –The MARVEL prospective registry
43. Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: a randomized comparison
44. Lack of Long-Term Clinical Benefit of Thrombus Aspiration During Primary Percutaneous Coronary Intervention With Paclitaxel-Eluting Stents or Bare-Metal Stents: Post-Hoc Analysis of the PASSION-Trial
45. Routine use of the transradial approach in primary percutaneous coronary intervention: procedural aspects and outcomes in 2209 patients treated in a single high-volume centre
46. A Randomized Comparison of Manual Versus Mechanical Thrombus Removal in Primary Percutaneous Coronary Intervention in the Treatment of ST-Segment Elevation Myocardial Infarction (TREAT-MI)
47. Primary percutaneous coronary intervention by magnetic navigation compared with conventional wire technique
48. PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY
49. Ticagrelor Monotherapy in Patients with Concomitant Diabetes Mellitus and Chronic Kidney Disease: A post hoc analysis of the GLOBAL LEADERS Trial
50. TCT CONNECT-260 A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus-Eluting Stent in the Treatment of Subjects With up to 2 De Novo Coronary Artery Lesions—BIOFLOW IV: 5-Year Clinical Results
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.